Skip to main content
. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355

Figure 1.

Figure 1

Immunotherapy treatment schema. (A) Schedule of overall dinutuximab, GM-CSF, IL2, and 13cisRA. (B) Treatment schema for courses 1, 3, and 5 with GM-CSF (28 days per course). (C) Treatment schema for courses 2 and 4 with IL2.